πŸ‡ΊπŸ‡Έ FDA
Patent

US 7488735

Quinuclidine amide derivatives

granted A61PA61P1/00A61P11/00

Quick answer

US patent 7488735 (Quinuclidine amide derivatives) held by Laboratories Almirall, S.A. expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Laboratories Almirall, S.A.
Grant date
Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/00, A61P11/00, A61P13/00, A61P25/02